OneFlorida Clinical Research Consortium bridges PCORnet and Florida CTSA Hubs
The OneFlorida Clinical Research Consortium was approved for a three-year, $7.9 million funding award by the Patient-Centered Outcomes Research Institute.
The OneFlorida Clinical Research Consortium was approved for a three-year, $7.9 million funding award by the Patient-Centered Outcomes Research Institute.
UF CTSI network science experts explore the application of network intervention strategies to the problem of assembling cross-disciplinary scientific teams in academic institutions.
The Florida Department of Health awarded $1.6 million to UF to help establish a statewide network that will more quickly bring the benefits of health research to more than 9 million patients in all of Florida’s 67 counties.
With a five-year, $9 million grant from the National Institutes of Health, the Southeast Center for Integrated Metabolomics will help chart the course of biomedical discovery in the newest of the “-omics” frontiers.
As doctors prepare to manage an influx of new hepatitis C patients and treatment options, a collaboration among academia, industry and the FDA is poised to deliver real-world data that can help.
U.S. Sen. Bill Nelson joined UF leaders for a ribbon-cutting ceremony to celebrate the opening of UF's Clinical and Translational Research Building, the new home of the CTSI and the Institute on Aging.
The Summer 2013 Florida Physician cover story explores how the Personalized Medicine Program and other CTSI-led efforts are helping to pave a new frontier in health care by transferring the latest scientific findings into the patient care setting.
Congratulations to the CTSI's own Dr. David R. Nelson on his assignment to the role of vice president for collaborative research in the life sciences by the UF Office of Research.
UF&Shands, the University of Florida Academic Health Center, is now University of Florida Health, university officials announced on May 20, 2013, during an event celebrating the three-year anniversary of the “Forward Together” strategic plan. UF Health will take the place of UF&Shands as the “umbrella” name that encompasses the academic…
HCV-TARGET observes how new therapies for hepatitis C are used and managed in routine practice to inform treatment guidelines and improve safety.